Pineda et al. used these probes to develop a bicistronic lentiviral-based system, Fucci2BL, to transduce primary human cells from normal and patient chronic phase myelogenous leukemic (CP CML) CD34+progenitor cells [62]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.